Incyte (INCY) PT Lowered to $144 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Incyte (INCY) PT Lowered to $148 at Jefferies Following CRL
April 17, 2017 6:44 AM EDTJefferies lowered its price target on Incyte (NASDAQ: INCY) to $148.00 (from $165.00) while maintaining a Buy rating after the "surprising" CRL on Olumiant.
Analyst Brian Abrahams said while there could be many possibilities for the FDA issue their best guess is... More

